Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.6M | 687 | 83.1% |
| Consulting Fee | $153,757 | 90 | 8.1% |
| Travel and Lodging | $105,448 | 479 | 5.5% |
| Food and Beverage | $33,683 | 857 | 1.8% |
| Education | $24,904 | 22 | 1.3% |
| Honoraria | $2,900 | 2 | 0.2% |
| Gift | $40.59 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $420,468 | 463 | $0 (2024) |
| United Therapeutics Corporation | $301,161 | 353 | $0 (2024) |
| GlaxoSmithKline, LLC. | $264,477 | 197 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $215,110 | 225 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $124,703 | 135 | $0 (2024) |
| Insmed, Inc. | $115,875 | 171 | $0 (2023) |
| GENZYME CORPORATION | $104,236 | 63 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $104,163 | 123 | $0 (2024) |
| Mylan Specialty L.P. | $78,521 | 107 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $56,473 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $326,539 | 344 | GENZYME CORPORATION ($100,472) |
| 2023 | $312,205 | 321 | Actelion Pharmaceuticals US, Inc. ($92,048) |
| 2022 | $254,504 | 206 | GlaxoSmithKline, LLC. ($69,364) |
| 2021 | $216,098 | 179 | GlaxoSmithKline, LLC. ($77,974) |
| 2020 | $186,677 | 220 | GlaxoSmithKline, LLC. ($56,097) |
| 2019 | $254,510 | 377 | Insmed, Inc. ($60,433) |
| 2018 | $185,205 | 258 | Actelion Pharmaceuticals US, Inc. ($73,818) |
| 2017 | $167,091 | 233 | Actelion Pharmaceuticals US, Inc. ($81,289) |
All Payment Transactions
2,138 individual payment records from CMS Open Payments — Page 1 of 86
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,527.00 | General |
| Category: Immunology | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,527.00 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.43 | General |
| Category: HFCWO | ||||||
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,527.00 | General |
| Category: Immunology | ||||||
| 12/11/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 12/11/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $300.00 | General |
| Category: SURGERY | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Education | In-kind items and services | $10.17 | General |
| 12/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,581.00 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,693.00 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $370.00 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $182.69 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $109.86 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | Cash or cash equivalent | $30.46 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: Immunology | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,249.00 | General |
| Category: Immunology | ||||||
| 11/27/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $106.35 | General |
| Category: SURGERY | ||||||
| 11/22/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 11/22/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $1,000.00 | General |
| Category: SURGERY | ||||||
| 11/22/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $300.00 | General |
| Category: SURGERY | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,693.00 | General |
| Category: Immunology | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,527.00 | General |
| Category: Immunology | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $308.89 | General |
| Category: Immunology | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | Cash or cash equivalent | $14.80 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,581.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,319 | 3,519 | $803,189 | $218,336 |
| 2022 | 26 | 2,386 | 3,975 | $821,408 | $237,937 |
| 2021 | 28 | 2,520 | 4,448 | $944,250 | $280,520 |
| 2020 | 35 | 3,149 | 5,694 | $1.1M | $338,694 |
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 207 | 918 | $148,794 | $54,779 | 36.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 171 | 348 | $94,020 | $31,390 | 33.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 70 | 167 | $107,876 | $27,470 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 306 | 440 | $81,840 | $27,418 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 176 | $46,640 | $15,923 | 34.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 84 | 84 | $34,092 | $10,862 | 31.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 118 | 118 | $26,786 | $9,445 | 35.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 91 | 95 | $35,185 | $9,319 | 26.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 107 | 119 | $55,133 | $5,302 | 9.6% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 35 | 35 | $21,781 | $4,262 | 19.6% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 31 | 32 | $27,365 | $3,110 | 11.4% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2023 | 28 | 31 | $9,052 | $2,416 | 26.7% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 19 | 19 | $10,019 | $2,393 | 23.9% |
| 93463 | Drug infusion during cardiac catheterization | Facility | 2023 | 31 | 31 | $8,122 | $2,329 | 28.7% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 32 | 32 | $15,040 | $2,280 | 15.2% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 106 | 113 | $6,893 | $1,880 | 27.3% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 20 | 20 | $34,873 | $1,465 | 4.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 22 | 22 | $5,808 | $1,361 | 23.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 186 | 195 | $7,857 | $1,360 | 17.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 184 | 186 | $5,552 | $1,142 | 20.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 123 | 125 | $4,125 | $1,077 | 26.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 94 | 94 | $2,586 | $559.80 | 21.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 61 | 61 | $2,013 | $480.48 | 23.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 31 | 32 | $2,560 | $306.88 | 12.0% |
| 31623 | Exam of lung airways using an endoscope | Facility | 2023 | 26 | 26 | $9,178 | $6.04 | 0.1% |
About Dr. Abhijit Raval, MD
Dr. Abhijit Raval, MD is a Internal Medicine healthcare provider based in Anderson, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508052275.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abhijit Raval, MD has received a total of $1.9M in payments from pharmaceutical and medical device companies, with $326,539 received in 2024. These payments were reported across 2,138 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.6M).
As a Medicare-enrolled provider, Raval has provided services to 10,374 Medicare beneficiaries, totaling 17,636 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist, Pulmonary Disease
- Location Anderson, SC
- Active Since 09/17/2007
- Last Updated 03/25/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508052275
Products in Payments
- UPTRAVI (Drug) $244,936
- TRELEGY ELLIPTA (Drug) $181,621
- DUPIXENT (Biological) $104,662
- Adempas (Drug) $104,163
- Arikayce (Drug) $88,837
- TYVASO (Drug) $83,750
- ANDEXXA (Biological) $73,277
- Yupelri (Drug) $67,141
- ORENITRAM (Drug) $65,527
- ACTHAR (Biological) $56,610
- OFEV (Drug) $54,011
- BREZTRI (Drug) $42,031
- OPSUMIT MACITENTAN (Drug) $32,818
- NONE (Drug) $30,250
- REMODULIN (Drug) $26,363
- Da Vinci Surgical System (Device) $24,745
- OPSUMIT (Drug) $24,016
- Letairis (Drug) $15,226
- WINREVAIR (Biological) $13,822
- YUPELRI (Drug) $11,380
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Anderson
Christopher Jennings, Md, MD
Internal Medicine — Payments: $1.4M
Dr. Anita Vagnoni, Md, MD
Internal Medicine — Payments: $55,715
Dr. Carl Sofley, Md, MD
Internal Medicine — Payments: $30,357
James Mcclain, M.d, M.D
Internal Medicine — Payments: $23,421
Robert Anderson, Md, MD
Internal Medicine — Payments: $13,599
Wael Bakdash, M.d, M.D
Internal Medicine — Payments: $12,031